The frequencies of recurrent genetic mutations and rearrangements in our whole T-ALL cohort were in agreement with other clinical data described in the literature, with CDKN2A/B deletions, NOTCH1 mutations and STIL-TAL1 gene fusion being the more prevalent alterations (12, 13, 30). The gene discussed is CDKN2A; the disease is acute lymphoblastic leukemia.